Pharmacist-led Continuous Glucose Monitoring

Description

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)

Conditions

Type 2 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)

Investigating the Impact of Pharmacist-led Flash Continuous Glucose Monitoring on Clinical and Behavioral Health Outcomes

Pharmacist-led Continuous Glucose Monitoring

Condition
Type 2 Diabetes
Intervention / Treatment

-

Contacts and Locations

Tampa

USF Health Department of Family Medicine - Morsani Center for Advanced Health Care, Tampa, Florida, United States, 33612

Tampa

USF Health Department of Family Medicine - University Partnership Center, Tampa, Florida, United States, 33613

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * type 2 diabetes
  • * hemoglobin A1c ≥ 8%
  • * compatible smartphone with FreeStyle Libre 2 continuous glucose monitoring system
  • * current use and access to a glucometer for self-monitoring of blood glucose
  • * any continuous glucose monitor use within 6 months prior to study enrollment
  • * pregnant and planning to become pregnant during study time frame
  • * history of hypoglycemia requiring third party assistance
  • * history of diabetic ketoacidosis or hyperosmolar hyperglycemic state within 6 months prior to study enrollment
  • * known allergy to medical grade adhesives
  • * current use of systemic steroids for any medical condition
  • * current use of dialysis

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of South Florida,

Kevin Cowart, PharmD, MPH, PRINCIPAL_INVESTIGATOR, University of South Florida

Study Record Dates

2025-08-05